← Evidence map

ReviewFrontiers in pharmacology2022

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment.

Xianbo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

56 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35614940